Journal of cardiothoracic and vascular anesthesia
-
J. Cardiothorac. Vasc. Anesth. · Dec 2003
Randomized Controlled Trial Clinical TrialPyruvate-enhanced cardioprotection during surgery with cardiopulmonary bypass.
To determine whether pyruvate-fortified cardioplegia solution provides cardioprotection superior to lactate-based cardioplegia solutions in patients undergoing elective coronary revascularization, with specific attention to post-surgical recovery of left ventricular performance as well as biochemical markers of ischemic injury. ⋯ Pyruvate-fortified cardioplegia mitigated myocardial injury during coronary artery bypass surgery and facilitated postsurgical recovery of cardiac performance. Thus, pyruvate-enhanced cardioplegia may provide cardioprotection superior to lactate-based solutions during surgical cardiac arrest.
-
J. Cardiothorac. Vasc. Anesth. · Dec 2003
Clinical TrialPropofol-ketamine mixture for anesthesia in pediatric patients undergoing cardiac catheterization.
To evaluate the safety of a propofol-ketamine mixture to induce and maintain anesthesia in spontaneously breathing pediatric patents during cardiac catheterization. ⋯ The propofol-ketamine mixture is a safe, practical alternative for general anesthesia in pediatric patients undergoing cardiac catheterization.
-
J. Cardiothorac. Vasc. Anesth. · Dec 2003
Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation.
Various preoperative, surgical, and postoperative markers of impaired outcome after orthotopic liver transplantation have been reported, but the influence of intraoperative hemodynamic aberrations has not been thoroughly investigated. ⋯ Hemodynamic events are independently associated with adverse outcomes after orthotopic liver transplantation.